2017
DOI: 10.3892/mmr.2017.6778
|View full text |Cite
|
Sign up to set email alerts
|

Phosphorothioate-modified antisense oligonucleotides against human telomerase reverse transcriptase sensitize cancer cells to radiotherapy

Abstract: Emergence of resistance, unavoidable systemic toxicity and unsatisfactory efficacy arethe main obstacles for traditional cancer therapy. Combination with phosphorothioate modified antisense oligonucleotides (PS‑ASODN) against human telomerase reverse transcriptase (hTERT) may enhance the therapeutic effect of irradiation. However, the effect of PS‑ASODN against hTERT on the anti‑tumor effects of irradiation in liver cancer remain unclear. In the current study, Walker 256 cells were transfected with hTERT PS‑AS… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
7
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 23 publications
0
7
0
Order By: Relevance
“…These predictions need to be validated. We note here that phosphorothioate-mediated augmentation of radiation damage to cells has already been reported and has been proposed to improve the radiotherapeutic efficacy of liver cancer …”
Section: Discussionmentioning
confidence: 85%
See 1 more Smart Citation
“…These predictions need to be validated. We note here that phosphorothioate-mediated augmentation of radiation damage to cells has already been reported and has been proposed to improve the radiotherapeutic efficacy of liver cancer …”
Section: Discussionmentioning
confidence: 85%
“…We note here that phosphorothioatemediated augmentation of radiation damage to cells has already been reported and has been proposed to improve the radiotherapeutic efficacy of liver cancer. 78 ■ ASSOCIATED CONTENT * sı Supporting Information…”
mentioning
confidence: 99%
“…DNA phosphorothioation is a fascinating phenomenon that holds high promise for potential application in gene silencing 45 and genome editing 46 , 47 . Phosphorothioated antisense oligonucleotides have also recently been used to target human telomerase for cancer therapy 48 . Our work might suggest clues for designing new generations of Cas9-like genome editing nucleases through utilizing the special PT-DNA recognition expertize of SBD domains.…”
Section: Discussionmentioning
confidence: 99%
“…siRNAs can be used for silencing the genes that contribute to radioresistance. An antisense oligonucleotide against telomerase reverse transcriptase is an example of the radiosensitizing function of oligonucleotides 78 . Knockdown of survivin by siRNA negatively modulated the inhibition of caspase activation, leading to increased apoptosis after RT 79 .…”
Section: Radiosensitizing Agentsmentioning
confidence: 99%